Latest News and Press Releases
Want to stay updated on the latest news?
-
Dublin, June 19, 2025 (GLOBE NEWSWIRE) -- The "Human Papillomavirus (HPV) Vaccines - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.The global market...
-
Dublin, April 30, 2025 (GLOBE NEWSWIRE) -- The "Cervarix Market Report 2025: Epidemiology, Pipeline Analysis, Market Insights & Forecasts" report has been added to ResearchAndMarkets.com's...
-
Dublin, Nov. 07, 2024 (GLOBE NEWSWIRE) -- The "Human Papillomavirus (HPV) Vaccine Market Report and Forecast 2024-2032" report has been added to ResearchAndMarkets.com's offering.The human...
-
Dublin, Sept. 05, 2024 (GLOBE NEWSWIRE) -- The "Cancer Vaccines Market Report by Type,, Technology, Indication, End User, and Region 2024-2032" report has been added to ResearchAndMarkets.com's...
-
Dublin, Jan. 22, 2024 (GLOBE NEWSWIRE) -- The "Cancer Vaccine Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028F" report has been added to ResearchAndMarkets.com's...
-
NEWARK, Del, Oct. 08, 2023 (GLOBE NEWSWIRE) -- The cervical dysplasia treatment market size is poised to cross US$ 628.5 million in 2023 and is likely to surpass a valuation of US$ 846.2 million by...
-
Dublin, Sept. 07, 2023 (GLOBE NEWSWIRE) -- The "Human Papillomavirus Vaccine Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028 Segmented By Valence, By Disease...
-
NEWARK, Del, March 08, 2023 (GLOBE NEWSWIRE) -- The global Cancer Vaccine Market is expected to grow significantly in the coming years, according to a new report published by Future Market Insights....
-
Dublin, Feb. 23, 2023 (GLOBE NEWSWIRE) -- The "Human Papillomavirus Vaccine Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2017-2027 Segmented By Valence (Bivalent,...
-
Dublin, Jan. 26, 2023 (GLOBE NEWSWIRE) -- The "Europe Human Papillomavirus Vaccine Market Forecast to 2028 - COVID-19 Impact and Regional Analysis - by Type, Dosage, Age, Application, and End User"...